🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Twist Bioscience Corporation

TWST Healthcare
$118.73 +$6.73 (6.01%)
Market Cap: $8.09 B
Gurus Holding
5
Popularity Rank
#1966
% of Shares Held
5.80%
Net Activity (Q3 2026)
-$146.86 M

Guru Ownership Trend

Guru Analysis for Twist Bioscience Corporation (TWST)

Twist Bioscience Corporation (TWST), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $469.88 M.

Top institutional holders include Catherine Wood and Steven Cohen.

Institutional sentiment is currently Bearish. This is evidenced by a $146.86 M net outflow during the quarter.

Recent activity highlights Ray Dalio who increased their stake by 345.3%. Conversely, Catherine Wood reduced exposure by 25.3%.

Key Holders

Top 5 by Value

$656.64 M
$66.33 M
$25.13 M
$16.04 M
$622,233

Top 5 by Conviction

Recent Activity Breakdown (Q3 2026)

+$78.9 M
Total Buy Value
New Buys 1
Additions 3
-$225.76 M
Total Sell Value
Reductions 1
Sold Out 1

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
2
Net Buyers
4

FAQs for Twist Bioscience Corporation (TWST)

Major holders include Catherine Wood ($656.64 M), Steven Cohen ($66.33 M), Cliff Asness ($25.13 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 3.96 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $146.86 M, with 4 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited TWST. The total reported sell value was $225.76 M.

Yes, 1 managers opened new positions in TWST, and 3 increased their existing holdings. The total reported buy value was $78.9 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
3.78% Reduce -25.3% 3,398,057 $656.64 M Q3 2026
0.07% New Buy 343,262 $66.33 M Q3 2026
0.01% Add 0.5% 130,021 $25.13 M Q3 2026
0.07% Add 345.3% 83,029 $16.04 M Q3 2026
0.00% Add 1.6% 3,220 $622,233 Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form